GSK PLC Sponsored ADR (GSK)
(Delayed Data from NYSE)
$40.91 USD
+0.05 (0.12%)
Updated Apr 25, 2024 04:00 PM ET
After-Market: $40.92 +0.01 (0.02%) 7:58 PM ET
3-Hold of 5 3
A Value C Growth F Momentum B VGM
Industry / Sector Report
Industry : Medical - Biomedical and Genetics
Zacks Industry Rank
Top 27% (69 out of 251)Zacks Sector Rank
Top 19% (3 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 3.00 | 2.10 | 9.99 |
Current Quarter Estimate | 0.94 | 37.64 | 60.00 |
Year Ago Quarter Estimate | 0.90 | 11.39 | 52.54 |
Next Quarter Estimate | 1.03 | 34.85 | 61.00 |
Next Year Estimate | 4.43 | 178.47 | 270.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 4.40 | 12.90 | 17.08 |
Next Year | 9.93 | 8.30 | 8.00 |
Last 5 Years | 0.10 | 1.00 | 8.10 |
Next 5 Years | 7.10 | 19.90 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | 10.61 | 15.53 |
Price/Book (MRQ) | 5.28 | 2.01 |
Price/Cash Flow (MRFY) | 7.88 | 14.08 |
Dividend Yield | 3.89% | 0.00% |
Net Profit Margin (TTM) | 16.24% | -100.99% |
Return on Equity (TTM) | 51.45% | -55.59% |
Debt to Equity (MRQ) | NA | 0.00 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.